𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Effect of Biological Effective Dose on Time to Symptom Progression in Metastatic Renal Cell Carcinoma

✍ Scribed by D. Wilson; L. Hiller; L. Gray; M. Grainger; A. Stirling; N. James

Book ID
108472917
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
150 KB
Volume
15
Category
Article
ISSN
1433-2981

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of antibody protein dose of a
The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts
✍ Marion H.Β G.Β C. Kranenborg; Otto C. Boerman; Mirjam C.Β A. de Weijert; Jeannette πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 2 views

## RESULTS. The relative uptake of G250 in NU-12 tumors was very high at low protein doses (125% injected dose/g [%ID/g]), but decreased at higher doses, suggesting

Effect of immunocompromise on metastatic
Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck
✍ Katherine E. Southwell; John M. Chaplin; Robert L. Eisenberg; Nicholas P. McIvor πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 1 views

Background. Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC). Methods. A retrospective analysis of patients with metastatic cutaneous SCC to the parotid and neck treated at Greenlane Hospital b

The inhibitory effect of connexin 32 gen
The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma
✍ Hiromi Sato; Hiromi Hagiwara; Hironobu Senba; Keiko Fukumoto; Yoji Nagashima; Hi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 267 KB

## Abstract We have previously reported that connexin (Cx) 32 gene, a member of gap junctions, was specifically downregulated in human renal cell carcinoma (RCC) and it acts as a tumor suppressor against RCC. Because there is no standard therapy for advanced RCC, we investigated the anti‐metastatic